Skip to main content

Table 1 Baseline characteristics of the patients in the two cohorts

From: Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial

 

Learning cohort (northern) N = 405

Validating cohort (southern) N = 353

Age (year) (median, IQR)

68 (59–77)

67 (57–75)

Apache II score (median, IQR)

21 (15–28)

19 (14–25)

Body mass index (kg/m2, median, IQR)

24.7 (22.8–27.7)

24.7 (22.2–27.7)

eGFR (ml/min/1.73 m2)

48.5 (26.4–78.9)

58.8 (33.5–93.5)

PaO2/FiO2 (Kpa, median, IQR)

19.4 (11.6–29.2)

21 (13.6–28.9)

Surfactant protein D (ng/mL, median, IQR)

133.5 (77.3–308.0)

112 (63.5–240.7)

Club cell secretory protein 16 (ng/mL, median, IQR)

25.4 (10.6–37.4)

20.2 (7.7–37.9)

Severe sepsis/septic shock, n (%)

158 (39.0)

149 (42.2)

Charlson’s comorbidity index, n (%)

 0

130 (32.1)

136 (38.5)

 1

139 (34.3)

108 (30.6)

 2

79 (19.5)

65 (18.4)

 3

34 (8.4)

30 (8.5)

 4

13 (3.2)

8 (2.3)

 5

6 (1.5)

2 (0.6)

 6

4 (1.0)

3 (0.9)

 7

0 (0.0)

1 (0.3)

COPD, n (%)

81 (20.0)

75 (21.3)

Primary admittance cause/acute diagnosis category (%)

 Pneumonia

137 (33.8)

117 (33.1)

 Abdominal sepsis

65 (16.1)

76 (21.5)

 Sepsis of other cause

48 (11.9)

42 (11.9)

 Heart failure

47 (11.6)

34 (9.6)

 Thrombosis or bleeding

52 (12.8)

20 (5.7)

 Other

56 (13.8)

64 (18.1)

Gender, n (%)

  

 Female

184 (45.4)

163 (46.2)

 Male

221 (54.6)

190 (53.8)

  1. y, years; IQR, interquartile range; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate—calculated by the Cockroft–Gault formula